Navigation Links
Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
Date:7/16/2008

Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

San Jose CA (PRWEB) July 16, 2008 -- Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

Clinical results on 32 patients with moderate to severe LSS have shown that all patients were discharged either the same day or the day following the MILD™ procedure. These patients were treated at 11 medical centers of excellence. No complications or adverse events were reported.

Clinical results included a 90% decrease in pain as measured by the Visual Analog Scale (VAS), as well as improved mobility, represented by a decrease in the Oswestry Disability Index
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
2. Medical And Nursing Scrubs Retailer Blue Sky Scrubs Unveils New Website
3. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
4. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
5. Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
6. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
7. The Five Biggest Marketing Mistakes Made By Medical Offices and Small Businesses
8. Medical Devices Get Most Funding in Slow Stretch for VC: Mid-Year Results from Healthcare Corporate Finance News
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Surgeons Use USGI Medicals EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference
11. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--He... advanceddiagnosticandspecialtyproductstotheveteri...nosticsCorporationforthesupplyofbloodgasproductsan..., (Logo: http://www.newscom.com/cgi-bin/prnh/20000...ssionforinnovatinginthefieldofadvancedpoint-of-car...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearch... Stelara report,thefirstinamulti-phasesyndicatedm...ho-Biotech,sStelara,fromproductlaunchthroughthefir...desquantitativeinformationfrom75uniqueDermatologis...rtsassesstrialanduseofStelara,obstaclestouse,typic...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBio...tofantithromboticaptamerswithactivecontrolagents,a...resentingatthePiperJaffray21stAnnualHealthCareConf...o,spresentationwillbegivenat1:10pm(EST)onTuesday,D...linewithemphasisontheleaddevelopmentprogram,theant...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Firm Parents Keep Teen Drivers Safe 58357 1Firm Parents Keep Teen Drivers Safe 58357 2Firm Parents Keep Teen Drivers Safe 58357 3Loyola University Chicago awarded scholarships for accelerated nursing students 58354 1Loyola University Chicago awarded scholarships for accelerated nursing students 58354 2M D Anderson scientist wins NIH New Innovator Award 58351 1M D Anderson scientist wins NIH New Innovator Award 58351 2M D Anderson scientist wins NIH New Innovator Award 58351 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: